Consultant Clinical Oncologist and Honorary Reader
Department of Radiotherapy, Royal Marsden Hospital and The Institute of Cancer Research, Sutton, United Kingdom
Dr Henry Mandeville is a Consultant Clinical Oncologist at The Royal Marsden and Honorary Reader at the Institute of Cancer Research. His research includes technical radiotherapy improvements for tumours in children and young people: motion management, MR-guided radiotherapy, proton therapy; and the quality of life of survivors. He has disease specific interests in paediatric and adolescent sarcoma, brain tumours, and neuroblastoma.
Dr Mandeville was appointed to the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) Board in December 2018, having been the EpSSG Radiotherapy Committee Chair from 2014 to 2020. He is the Local Therapy lead for the new EpSSG Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) study, the SIOPe QUARTET project Chair, the joint radiotherapy lead for the International Soft Tissue Sarcoma Consortium (INSTRuCT), NCRI Sarcoma group member and the Young Onset Soft Tissue Sarcoma Subgroup Chair.
